Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

First Carbonhand prescribed to a US Veteran

Published 07/02/2024, 14:59

John Lamb, a US veteran living in Montana, is the first patient in the United States to be prescribed  Carbonhand to assist with daily activities. Carbonhand is available to all US veterans through a network of sales agents covering over 80% of VA Medical Centers across the US. This first prescription paves the way for other US Veterans with impaired hand function to regain hand function and become more independent.

KISTA, Sweden, Feb. 7, 2024 /PRNewswire/ -- Mr. Lamb has inclusion body myositis ( IBM (NYSE:IBM)), a rare autoimmune disease that primarily affects skeletal muscles with reduced muscle strength and endurance as characteristic symptoms. IBM differs from other types of autoimmune diseases with slowly progressive muscle weakness and muscle atrophy, finger flexor weakness is a central and early presenting symptom. Patients experience challenges in many areas of their lives. Gripping and holding objects as well as fine-motor activities are major parts of the challenges they face. Individuals with advanced IBM have difficulties holding utensils, gripping a glass to drink, holding a toothbrush, dressing and undressing as well as many other activities of daily living requiring grip.  

Carbonhand is a medical device in the form of a grip-enhancing glove that enables people with impaired hand function, like IBM, to regain the ability to use their hands. Sensors in the glove send signals to a sophisticated control system that activates motors that pull on artificial tendons sewn into the glove, creating a natural and dynamic grip. Several studies show that people with impaired hand function get a sustained and strong grip with Carbonhand, improving the user's ability to perform activities of daily living.

"I have lost 90% of my grip strength and have had difficulty doing everyday tasks, with the help of Carbonhand I can suddenly do things on my own and not rely on my wife and family to help me. I am very grateful for this opportunity and look forward to having a more active life again," says John Lamb, US Veteran.

"Carbonhand is fully covered by Veteran Affairs, and since its introduction in the US, we have met many veterans with different diagnoses whom can benefit from improved grip through the use of Carbonhand. We already have several veterans in various stages of the prescription process throughout the US and we are excited for them and their families at the opportunity for these veterans to benefit from Carbonhand. This breakthrough at Ford (NYSE:F) Harrison VA Medical Center in Montana marks the starting point for helping many veterans regain their freedom and independence," said Loren Wass, US Commercial Manager at Bioservo.

For more information, please contact

Loren Wass, US Commercial Manager at Bioservo AB
Phone: +1 978-502-6330
Email: loren.wass@bioservo.com

Mikael Wester, Marketing Director at Bioservo AB
Phone: +4670 721 12 80
Email: mikael.wester@bioservo.com

About  Bioservo

Bioservo AB is a world-leading company in wearable muscle-strengthening systems for people who need extra strength and endurance. Our innovative products and systems are designed to improve the quality of life for our users and make them feel safe and independent. The company has a unique global position in soft active exoskeletons for the hand, which give people back the ability to manage their everyday lives and become independent and able to perform their tasks while maintaining health.

Bioservo AB is a Swedish limited company with headquarters and operations in Kista, north of Stockholm. For more information, please visit www.bioservo.com

View original content:https://www.prnewswire.com/news-releases/first-carbonhand-prescribed-to-a-us-veteran-302056182.html

SOURCE Bioservo AB

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.